ANJAC Health & Beauty is expanding GLP-1 companion platforms with a multi-category offering designed to support patients throughout and after treatment. The GLP-1 Companion platform addresses needs including digestive comfort, hydration, micronutrient balance, muscle preservation, and skin and hair care. Its portfolio spans medicines, medical devices, food supplements and cosmetics, with products available as turnkey solutions, complete portfolios, à la carte options or bespoke developments. ANJAC is also conducting substantiation studies involving GLP-1 patients to support product benefit claims.
The platform gives pharmaceutical, consumer healthcare, beauty and wellness companies a way to enter the growing market surrounding GLP-1 use without developing every product internally. For ANJAC, combining its formulation, manufacturing and regulatory capabilities can create cross-category partnerships while positioning the company as a single provider for brands addressing treatment-related and post-treatment needs.
Image Credit: ANJAC Health & Beauty
Why This Trend Is Growing
- GLP-1 Support Ecosystems
- Integrated companion offerings create space for brands to address digestive, hydration, nutritional and aesthetic needs connected to weight-loss medication journeys.
- Cross-category Health Portfolios
- Blended formats spanning supplements, cosmetics, devices and medicines signal new models for companies seeking broader consumer care relevance.
- Claims-backed Wellness Products
- Clinical substantiation around GLP-1 patient needs strengthens differentiation in a market where efficacy, compliance and trust are increasingly important.
Industries Being Reshaped
- Consumer Healthcare
- Adjacent care platforms expand the role of over-the-counter products in supporting patients before, during and after prescription-led treatments.
- Beauty and Personal Care
- Skin, hair and body concerns linked to metabolic treatment open new territory for cosmetic brands to connect beauty outcomes with health transitions.
- Pharmaceutical Manufacturing
- Turnkey development and regulatory expertise enable outsourced innovation for companies entering fast-growing therapeutic-adjacent categories.
